Todenhöfer, Tilman http://orcid.org/0000-0003-4432-2741
Maas, Moritz
Ketz, Miriam
Kossack, Nils
Colling, Christiane
Qvick, Bryan
Stenzl, Arnulf
Funding for this research was provided by:
Ipsen Pharma GmbH
Projekt DEAL
Article History
Received: 27 September 2020
Accepted: 29 December 2020
First Online: 10 February 2021
Compliance with ethical standards
:
: Tilman Todenhöfer: speaker/advisor for Amgen, Astellas, AstraZeneca, Bayer, BMS, Ipsen, Janssen, MSD, Roche. Moritz Maas: none. Miriam Ketz: none. Nils Kossack: none. Christiane Colling: former employee of Ipsen Pharma. Bryan Qvick: employee of Ipsen Pharma. Arnulf Stenzl: speaker/advisor for Alere, Amgen, Astellas, Bristol Myers Squibb, CureVac, Ferring, Ipsen, Janssen, Roche, Sanofi Aventis, Stebabiotech, Synergo.
: This work is based on routine healthcare claims data. As anonymized and pseudonymized healthcare claims data were evaluated, the study was exempt from ethical approval, no informed consent was required.
: This work did not include animal studies. Data concerning human patients were collected retrospectively.